Novartis Aktie

90.90 CHF 0.68CHF 0.75%
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Strukturierte Produkte
>

Aktionärsstruktur

Inhaber in %
Freefloat 84.31
Novartis AG 9.39
Sandoz Family Foundation 3.49
Novartis Foundation For Employee Participation 2.57
The Vanguard Group, Inc. 2.48
Norges Bank Investment Management 2.14
Capital Research & Management Co. (Global Investors) 1.93
Wellington Management Co. LLP 1.64
UBS AG (Investment Management) 1.61
Capital Research & Management Co. (World Investors) 1.50
BlackRock Fund Advisors 1.22
Zürcher Kantonalbank (Investment Management) 0.99
Credit Suisse Asset Management (Schweiz) AG 0.83
Dodge & Cox 0.63
JPMorgan Asset Management (UK) Ltd. 0.47

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2014 2015 2016 2017 2018
Personal am Ende des Jahres 133'413 118'700 118'393 121'597 125'161
Umsatz pro Mitarbeiter in Mio. EUR 0.36 0.40 0.40 0.40 0.41

Bilanz (in Mio. EUR) - Aktiva

2014 2015 2016 2017 2018
Summe Umlaufvermögen 37'322 22'867 25'338 27'488 35'058
Summe Anlagevermögen 90'546 99'076 100'247 99'977 109'132
Summe Aktiva 124'967 132'037 132'519 129'833 143'578

Bilanz (in Mio. EUR) - Passiva

2014 2015 2016 2017 2018
Gesamtverschuldung/ -verbindlichkeiten 20'229 21'952 24'191 27'700 31'634
Summe Fremdkapital 54'573 54'838 56'403 57'498 66'003
Summe Eigenkapital 70'394 77'199 76'115 72'334 77'575
Summe Passiva 124'967 132'037 132'519 129'833 143'578

Adresse

Lichtstrasse 35, 4056 Basel
Telefon 41613241111
Fax 41613248001
Internet http://www.novartis.com

Management

Ameet Mallik
Head-Global Marketing, Value & Access
Andreas von Planta, PhD
Independent Non-Executive Director
Ann Marie Fudge, MBA
Independent Non-Executive Director
Antonio Ligi
Head-Global Media Relations
Bertrand Bodson PhD, MBA
Chief Digital Officer
Charles L. Sawyers, MD
Independent Non-Executive Director
Charlie Hough
VP & Global Head-Strategy
Charlotte Pamer-Wieser, PhD
Secretary
Dan Bar-Zohar, MD
Global Head-Neuroscience Development
David Lebwohl
SVP & Franchise Global Program Head
Elizabeth Theophille
Chief Technology & Digital Officer
Enrico Cipro Vanni PhD, MBA
Vice Chairman
Frans van Houten
Independent Non-Executive Director
Hans Jörg Reinhardt, PhD
Independent Non-Executive Chairman
Harry Werner Kirsch
Chief Financial Officer
Isabella Zinck
Investor Relations Contact
James E. Bradner, MD
Member-Executive Committee
Janneke van der Kamp
Member Executive Committee
Jeffrey Engelman, PhD
Vice President & Global Head-Oncology NIBR
John Tsai, MD
Chief Medical Officer
Klaus Moosmayer, PhD
Chief Ethics Risk & Compliance Officer
Lilli Petruzzelli
Global Head-Immuno-Oncology
Mark Levick
Global Head
Mary Elizabeth Doherty
Independent Non-Executive Director
Michael Willi
Group Head-Communications
Mimi Huizinga, MD
VP & Head-Strategic Data
Nancy C. Andrews MD, PhD
Independent Non-Executive Director
Natacha Theytaz
Head-Internal Audit
Patrice Bula
Director
Paul Barrett
Global Head-External Communications
Paul Hudson
Member-Executive Committee
Pierre-Michel Bringer
Investor Relations Contact
Samir Shah, MD
Global Head-Investor Relations
Samit Hirawat
Head- Global Oncology Development
Shannon Thyme Klinger, PhD
Group General Counsel
Srikant T. Madhav Datar, PhD
Independent Non-Executive Director
Steffen Lang, PhD
Global Head-Technical Operations
Stephen Moran, PhD
Global Head-Strategy
Steven Baert, MBA
Head-Human Resources
Thomas Hungerbühler
Investor Relations Contact
Ton Büchner, MBA
Independent Non-Executive Director
Vasant Narasimhan, MD
Chief Executive Officer
William Thomas Winters, MBA
Independent Non-Executive Director

Eintrag hinzufügen